Requests · Health and Human Services Commission

Medicaid Entitlement Cost Growth

Priority 1 · one of 38 items in the Health and Human Services Commission's request for 2028-29 · The item begins on page 789 of the request

This is a request, not an appropriation.

What is asked

20282029Two years
All funds$1,513,913,404$3,080,945,611$4,594,859,015
Of which general revenue and general revenue-dedicated $613,100,330$1,250,506,172$1,863,606,502
Positions (full-time equivalents) ——

How it would be financed

Method of financing, as the request prints it20282029
1 General Revenue Fund$10,659,500$11,837,490
93.767.000 CHIP$27,822,941$53,480,143
93.767.778 CHIP for Medicaid (EFMAP)$23,081,793$30,965,530
93.778.000 XIX FMAP$846,643,831$1,739,594,171
93.778.003 XIX 50%$962,209$1,923,874
93.778.005 XIX FMAP @ 90%$2,276,663$4,431,912
93.778.007 XIX ADM @ 100$25,637$43,809
758 GR Match For Medicaid$592,049,374$1,203,354,628
8092 Medicare Giveback Provision$10,391,456$35,314,054
Total, as the request prints it$1,513,913,404$3,080,945,611

Where it would land

The strategies this item would add to, numbered as the request numbers them, beside what each is appropriated in the current budget (2026-27 Act). One column is an appropriation and the other a request made on top of a base request not shown here, so the two are not subtracted.

Strategy Asked 2028Asked 2029Positions Appropriated 2026Appropriated 2027
01-01-01 Medicaid Client ServicesIn the current budget: A.1.1 MEDICAID CLIENT SERVICES $1,475,432,732$3,015,632,280— $36,391,084,988 $37,196,284,104
03-01-01 CHIP, Perinatal Services, Prescription Drugs, And Dental ServicesIn the current budget: C.1.1 CHIP $27,822,941$53,480,143— $694,560,334 $695,457,220
05-01-01 Temporary Assistance for Needy Families GrantsIn the current budget: E.1.1 TANF (CASH ASSISTANCE) GRANTS $10,657,731$11,833,188— $24,285,518 $24,588,227

A strategy is matched by its name. Where none is matched, the strategy may be new, or may be in the current budget under a different name.

After 2029

The request marks this item as having no costs after 2029.

The agency's justification

The EI request to maintain Medicaid and CHIP cost growth provides for the incremental cost increase in FY 2028-29 over FY 2027 levels for all acute and LTSS entitlements. The maintain TANF funding EI includes caseload and cost growth need beyond FY 2026-27 appropriated amounts. The Medicaid entitlement and CHIP baseline requests include projected caseload growth at FY 2027 average cost, Medicaid non-entitlement cost growth and caseload growth are a separate request.

Cost growth from utilization and acuity changes, inflation or evolving/new services, must be requested as an EI. Federal Medical Assistance Percentage (FMAP) rates of 58.96% for FY 2028 and 59.00% for FY 2029 are assumed, with additional match of 6 percentage points for CFC. Enhanced FMAP rates of 71.27% for FY 2028 and 71.30% for FY 2029 are assumed for CHIP, MCHIP, Qualified Aliens, and Breast & Cervical Cancer clients. The match rate for family planning services is 90%.

Overall, the Medicaid entitlement maintain annual cost growth trend is 3.7% for FY 2028 and 3.6% for FY 2029, or 3.7% per year.

For CHIP overall, the maintain annual cost growth trend is 3.8% in FY 2028 and 3.2% in FY 2029, or 3.5% per year. Perinatal makes up 23.8% of the total CHIP program exceptional item.

For TANF overall, the all-fund EI request for the biennium is 42.7% over FY 2026-27 appropriated amounts. TANF projections include annual recipient growth of 1.2% over the biennium and annual cost growth of 3.2% in FY 2028 and 3.1% in FY2029. The TANF EI request will help re-align appropriations with current caseload and average monthly grant cost levels.

External and internal factors

Some cost elements are not controlled by the state. For example, the federal matching rate and Medicare related payments are set by the federal government. They determine the Medicare part D (clawback) and Part A/B rates that states pay for dual eligible clients. Federal regulations can increase state costs. In addition, some medical cost increases can be attributed to changes in medical technology, the adoption of new procedures and drugs, and changes in medical practice.

As marked in the request